PubMed Health⌕ Search

PubMed · 6443570

A practical guide for routine EEG studies in epilepsy.

Abstract

Know what is not epilepsy! An electroencephalographer can do much more damage by overinterpreting than by underinterpreting an EEG tracing. Epilepsy is a clinical, not an EEG, diagnosis, but the EEG, when used appropriately, can greatly aid the diagnostic process. Use activating techniques such as hyperventilation, photic stimulation, and natural sleep. Take advantage of seizures in the laboratory--this is a unique opportunity to make a diagnosis. If the ictal event is not accompanied by an EEG abnormality, and pseudoseizures are suspected, remember that patients with hysterical epilepsy often have real seizures as well. Use the EEG to help differentiate between generalized and partial epileptic conditions, and to identify benign epileptic syndromes. These diagnoses have important prognostic and therapeutic implications. The EEG can help determine whether a patient is deteriorating due to increased seizure activity (undermedicated) or increased side effects (overmedicated). Postictal slowing must be differentiated from progressive or drug induced changes. The best candidates for resective surgical therapy are otherwise healthy young adults with medically intractable partial complex seizures, no psychosis, and unilateral or bilaterally independent interictal anterior temporal EEG spike foci. Patients with multifocal or bilaterally synchronous interictal EEG spikes combined with mental retardation are less likely to benefit from resective surgery, although they may be helped by corpus callosum section.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Engel. 1984. A practical guide for routine EEG studies in epilepsy.. https://doi.org/10.1097/00004691-198404000-00001

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

Medical therapy for essential tremor (ET), a common movement disorder, is often inadequate. We performed a double-blind placebo-controlled randomized trial to evaluate the efficacy and tolerability of zonisamide (ZNS), an antiepileptic agent, in treating ET. Twenty patients (mean age, 60 +/- 15 years) with ET were randomized to receive ZNS or placebo. ZNS was initiated at a dosage of 100 mg/day and escalated to 200 mg/day at day 14. Patients were evaluated by accelerometry and the Fahn-Tolosa-Marin (FTM) rating scale at baseline and days 14 and 28, as well as the Clinical Global Impression (CGI-C) scale at day 28. At endpoint, subjects assigned to ZNS were taking a mean dosage of 160 +/- 50 mg/day. There were no significant improvements in the FTM total score or its subsections. Tremor amplitude as assessed by accelerometry significantly improved in the ZNS group compared to the placebo group at endpoint relative to baseline (-0.50 +/- 0.72 vs. 0.30 +/- 0.79 m/s(2); P = 0.03). On the CGI-C, 60% (n = 6) of patients in the ZNS group felt that their tremor was unchanged, while the remaining patients felt that their tremor was "minimally improved." Thirty percent (n = 3) of patients taking ZNS discontinued the study due to side effects (fatigue, headache, paresthesias) while taking 100 mg per day. ZNS did not provide significant improvements in clinical rating scales at study endpoint compared to placebo and was only modestly well tolerated. ZNS was effective in reducing tremor amplitude as measured by accelerometry.

Anticonvulsants↗